Papanicolaou Test

• 

  Subject Areas on Research

  • A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. 
  • Abnormal outcomes following cervical cancer screening: event duration and health utility loss. 
  • Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. 
  • An abnormal cervicovaginal cytology smear in uterine carcinosarcoma is an adverse prognostic sign: analysis of 25 cases. 
  • Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Study. 
  • Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. 
  • Awareness of Cervical Cancer Causes and Predeterminants of Likelihood to Screen Among Women in Haiti. 
  • Barriers to Breast and Cervical Cancer Screening in Singapore: a Mixed Methods Analysis. 
  • Cancer screening before and after switching to a high-deductible health plan. 
  • Cancer screening behaviors and attitudes of women in southeastern Minnesota. 
  • Cervical Cancer Screening. 
  • Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. 
  • Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. 
  • Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. 
  • Costs of integrating cervical cancer screening at an HIV clinic in Kenya. 
  • Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias. 
  • De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. 
  • Demand for Cancer Screening Services: Results From Randomized Controlled Discrete Choice Experiments. 
  • Do proficiency test results correlate with the work performance of screeners who screen Papanicolaou smears? 
  • Effectiveness of health maintenance reminders provided directly to patients. 
  • Eubacterium nodatum mimics Actinomyces in intrauterine device-associated infections and other settings within the female genital tract. 
  • Evaluating a stage model in predicting monolingual spanish-speaking Latinas' cervical cancer screening practices: the role of psychosocial and cultural predictors. 
  • Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. 
  • HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. 
  • Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. 
  • Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. 
  • Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening. 
  • Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. 
  • Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. 
  • Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias. 
  • Knowledge about human papillomavirus among adolescents. 
  • Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review. 
  • Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5. 
  • National trends and disparities in cervical cancer screening among commercially insured Women, 2001-2010. 
  • Pain predicts non-adherence to pap smear screening among middle-aged African American women. 
  • Pediatricians are more supportive of the human papillomavirus vaccine than the general public. 
  • Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. 
  • Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. 
  • Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. 
  • Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). 
  • Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. 
  • The effect of comorbid illness on receipt of cancer screening by older people. 
  • The impact of health status on physicians' intentions to offer cancer screening to older women. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.